Re:Cognition Health Becomes the First Organization to Earn Internationally Recognized GCSA Certification in the US and Europe
At Re:Cognition Health, we are proud to announce a monumental achievement: we have become the first organization to earn the prestigious GCSA Certification in both the US […]
The Benefits of Alzheimer’s Clinical Trials
This is an exciting time for Alzheimer’s clinical trials, with leaps and bounds of progress in the development of new-generation treatments over the last few years. Due […]
Dr. Emer MacSweeney talks new treatments on Good Morning Washington
New Alzheimer’s Disease Prevention Developments
A recent study from R. Scott Turner, PHD, MD–one of our Principal Investigators at Re:Cognition Health USA–shows that both mild cognitive impairment (MCI) and dementia cases are […]
Groundbreaking Early Alzheimer’s Detection Potentially Found
An early study was done using blood testing to discover Alzheimer’s ahead of time. The tests track certain protein problems and levels in the blood that […]
Leukemia Drug Shown to Lower Risk of Alzheimer’s
The first oral drug shown to combat Alzheimer’s causing proteins in patients A research study on Nilotinib, an FDA-approved drug which is used to treat Leukemia, has […]
Activ8 Your Brain
8 Steps to Brain Wellness We all know the best ways to take care of our bodies: exercise for heart and lungs; lift weights to keep muscles […]
Sleep Deprivation
Long-term sleep deprivation can lead to higher levels of amyloid beta plaques in the brain The buildup of these plaques contributes to brain diseases such as Alzheimer’s disease. […]
Dementia Rates
Reduction in number of people smoking leads to decline in dementia rates According to new research, dementia rates have fallen by 15% per decade over the last […]
Dr Dimitrios Paschos Talks To Primal Cure TV
Dr Dimitrios Paschos interviewed by Primal Cure TV, Sky’s no.1 health channel The Re:Cognition Health Consultant Psychiatrist specialises in the mental health of adults with learning and […]
Visit our UK website
